Abstract
Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease with prominent chronic inflammatory aspects. SLE most often affects women (9:1) in childbearing age. The multifactorial nature of the etiopathogenesis of SLE involves a deficient clearance of dead and dying cells. This is supported by the occurrence of autoantibodies directed against autoantigens modified in dying and dead cells (dsDNA, high mobility group box 1 protein, apoptosis-associated chromatin modifications, e.g., histones H3-K27-me3; H2A/H4 AcK8,12,16; and H2B-AcK12) that are deposited in various tissues, including skin, kidneys, joints, muscles, and brain. The subsequent hyperinflammatory response often leads to irreparable tissue damage and organ destruction. In healthy individuals, dead and dying cells are rapidly removed by macrophages in an anti-inflammatory manner, referred to as efferocytosis. In SLE, extensive and prolonged cell death (apoptosis, necrosis, neutrophil extracellular trap (NET) formation) leads to autoantigens leaking out of the not cleared cell debris. These neo-epitopes are subsequently presented to B cells by follicular dendritic cells in the germinal centers of secondary lymphoid tissues conditioning the break of self-tolerance. Activation of autoreactive B cells and subsequent production of autoantibodies facilitate the formation of immune complexes (ICs) fueling the inflammatory response and leading to further tissue damage. ICs may also be ingested by phagocytes, which then produce further pro-inflammatory cytokines. These processes establish a vicious circle that leads to sustained inflammation. This review highlights the cell death–related events in SLE, the protagonists involved in SLE pathogenesis, the resolution of inflammation in various tissues affected in SLE, and explores strategies for intervention to restore hemostasis in a hyperinflammatory state.
Similar content being viewed by others
References
Bursch W, Ellinger A, Gerner C, Frohwein U, Schulte-Hermann R (2000) Programmed cell death (PCD). Apoptosis, autophagic PCD, or others? Ann N Y Acad Sci 926:1–12
D'Arcy MS (2019) Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int 43(6):582–592. https://doi.org/10.1002/cbin.11137
Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F (1997) Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 27(1):1–20
Cenciarelli C, Tanzarella C, Vitale I, Pisano C, Crateri P, Meschini S, Arancia G, Antoccia A (2008) The tubulin-depolymerising agent combretastatin-4 induces ectopic aster assembly and mitotic catastrophe in lung cancer cells H460. Apoptosis : an international journal on programmed cell death 13(5):659–669. https://doi.org/10.1007/s10495-008-0200-2
Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A (2004) Neutrophil extracellular traps kill bacteria. Science 303(5663):1532–1535. https://doi.org/10.1126/science.1092385
Pieterse E, Rother N, Yanginlar C, Hilbrands LB, van der Vlag J (2016) Neutrophils discriminate between lipopolysaccharides of different bacterial sources and selectively release neutrophil extracellular traps. Front Immunol 7:484. https://doi.org/10.3389/fimmu.2016.00484
Rochael NC, Guimaraes-Costa AB, Nascimento MT, DeSouza-Vieira TS, Oliveira MP, Garcia e Souza LF, Oliveira MF, Saraiva EM (2015) Classical ROS-dependent and early/rapid ROS-independent release of neutrophil extracellular traps triggered by Leishmania parasites. Sci Rep 5:18302. https://doi.org/10.1038/srep18302
Mahajan A, Gruneboom A, Petru L, Podolska MJ, Kling L, Maueroder C, Dahms F, Christiansen S, Gunter L, Krenn V, Junemann A, Bock F, Schauer C, Schett G, Hohberger B, Herrmann M, Munoz LE (2019) Frontline Science: Aggregated neutrophil extracellular traps prevent inflammation on the neutrophil-rich ocular surface. J Leukoc Biol. https://doi.org/10.1002/JLB.HI0718-249RR
Schauer C, Janko C, Munoz LE, Zhao Y, Kienhofer D, Frey B, Lell M, Manger B, Rech J, Naschberger E, Holmdahl R, Krenn V, Harrer T, Jeremic I, Bilyy R, Schett G, Hoffmann M, Herrmann M (2014) Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med 20(5):511–517. https://doi.org/10.1038/nm.3547
Appelt U, Sheriff A, Gaipl US, Kalden JR, Voll RE, Herrmann M (2005) Viable, apoptotic and necrotic monocytes expose phosphatidylserine: cooperative binding of the ligand Annexin V to dying but not viable cells and implications for PS-dependent clearance. Cell Death Differ 12(2):194–196. https://doi.org/10.1038/sj.cdd.4401527
Meesmann HM, Fehr EM, Kierschke S, Herrmann M, Bilyy R, Heyder P, Blank N, Krienke S, Lorenz HM, Schiller M (2010) Decrease of sialic acid residues as an eat-me signal on the surface of apoptotic lymphocytes. J Cell Sci 123(Pt 19):3347–3356. https://doi.org/10.1242/jcs.066696
Pieterse E, Hofstra J, Berden J, Herrmann M, Dieker J, van der Vlag J (2015) Acetylated histones contribute to the immunostimulatory potential of neutrophil extracellular traps in systemic lupus erythematosus. Clin Exp Immunol 179(1):68–74. https://doi.org/10.1111/cei.12359
Mahajan A, Herrmann M, Munoz LE (2016) Clearance deficiency and cell death pathways: a model for the pathogenesis of SLE. Front Immunol 7:35. https://doi.org/10.3389/fimmu.2016.00035
Birge RB, Boeltz S, Kumar S, Carlson J, Wanderley J, Calianese D, Barcinski M, Brekken RA, Huang X, Hutchins JT, Freimark B, Empig C, Mercer J, Schroit AJ, Schett G, Herrmann M (2016) Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer. Cell Death Differ 23(6):962–978. https://doi.org/10.1038/cdd.2016.11
Mikolajczyk TP, Skiba D, Batko B, Krezelok M, Wilk G, Osmenda G, Pryjma JR, Guzik TJ (2014) Characterization of the impairment of the uptake of apoptotic polymorphonuclear cells by monocyte subpopulations in systemic lupus erythematosus. Lupus 23(13):1358–1369. https://doi.org/10.1177/0961203314541316
Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM (1992) Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 149(12):4029–4035
Barth ND, Marwick JA, Vendrell M, Rossi AG, Dransfield I (2017) The “phagocytic synapse” and clearance of apoptotic cells. Front Immunol 8:1708. https://doi.org/10.3389/fimmu.2017.01708
Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL, Kirchner T, Kalden JR, Herrmann M (2002) Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 46(1):191–201. https://doi.org/10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K
Trahtemberg U, Mevorach D (2017) Apoptotic cells induced signaling for immune homeostasis in macrophages and dendritic cells. Front Immunol 8:1356. https://doi.org/10.3389/fimmu.2017.01356
Sousa C, Pereira I, Santos AC, Carbone C, Kovacevic AB, Silva AM, Souto EB (2017) Targeting dendritic cells for the treatment of autoimmune disorders, colloids and surfaces. B, Biointerfaces 158:237–248. https://doi.org/10.1016/j.colsurfb.2017.06.050
Hargraves MM (1949) Production in vitro of the L.E. cell phenomenon; use of normal bone marrow elements and blood plasma from patients with acute disseminated lupus erythematosus. Proc Staff Meet Mayo Clin 24(9):234–237
Schett G, Steiner G, Smolen JS (1998) Nuclear antigen histone H1 is primarily involved in lupus erythematosus cell formation. Arthritis Rheum 41(8):1446–1455. https://doi.org/10.1002/1529-0131(199808)41:8<1446::AID-ART15>3.0.CO;2-6
Bartl MM, Luckenbach T, Bergner O, Ullrich O, Koch-Brandt C (2001) Multiple receptors mediate apoJ-dependent clearance of cellular debris into nonprofessional phagocytes. Exp Cell Res 271(1):130–141. https://doi.org/10.1006/excr.2001.5358
Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26(4):239–257
Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR (1998) Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41(7):1241–1250. https://doi.org/10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H
Boeltz SK, Deborah, Markus H (2013) Wolves in sheep’s clothing: how chemically inert hydrocarbon oils induce autoimmunity. Immunome Res 9. https://doi.org/10.4172/1745-7580.1000071
Henson PM, Bratton DL, Fadok VA (2001) Apoptotic cell removal. Current biology : CB 11(19):R795–R805
Vandivier RW, Henson PM, Douglas IS (2006) Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 129(6):1673–1682. https://doi.org/10.1378/chest.129.6.1673
Biermann MH, Podolska MJ, Knopf J, Reinwald C, Weidner D, Maueroder C, Hahn J, Kienhofer D, Barras A, Boukherroub R, Szunerits S, Bilyy R, Hoffmann M, Zhao Y, Schett G, Herrmann M, Munoz LE (2016) Oxidative burst-dependent NETosis is implicated in the resolution of necrosis-associated sterile inflammation. Front Immunol 7:557. https://doi.org/10.3389/fimmu.2016.00557
Biermann MHC, Boeltz S, Pieterse E, Knopf J, Rech J, Bilyy R, van der Vlag J, Tincani A, Distler JHW, Kronke G, Schett GA, Herrmann M, Munoz LE (2018) Autoantibodies recognizing secondary NEcrotic cells promote neutrophilic phagocytosis and identify patients with systemic lupus erythematosus. Front Immunol 9:989. https://doi.org/10.3389/fimmu.2018.00989
Choi JJ, Reich CF 3rd, Pisetsky DS (2005) The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells. Immunology 115(1):55–62. https://doi.org/10.1111/j.1365-2567.2005.02130.x
Morimoto K, Janssen WJ, Fessler MB, McPhillips KA, Borges VM, Bowler RP, Xiao YQ, Kench JA, Henson PM, Vandivier RW (2006) Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J Immunol 176(12):7657–7665
Thorp E, Subramanian M, Tabas I (2011) The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis. Eur J Immunol 41(9):2515–2518. https://doi.org/10.1002/eji.201141719
Davidson A, Bethunaickan R, Berthier C, Sahu R, Zhang W, Kretzler M (2015) Molecular studies of lupus nephritis kidneys. Immunol Res 63(1–3):187–196. https://doi.org/10.1007/s12026-015-8693-6
Hakkim A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, Herrmann M, Voll RE, Zychlinsky A (2010) Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A 107(21):9813–9818. https://doi.org/10.1073/pnas.0909927107
Elkon KB, Santer DM (2012) Complement, interferon and lupus. Curr Opin Immunol 24(6):665–670. https://doi.org/10.1016/j.coi.2012.08.004
Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, Punaro M, Baisch J, Guiducci C, Coffman RL, Barrat FJ, Banchereau J, Pascual V (2011) Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3(73):73ra20. https://doi.org/10.1126/scitranslmed.3001201
Zhang Y, Shi W, Tang S, Li J, Yin S, Gao X, Wang L, Zou L, Zhao J, Huang Y, Shan L, Gounni AS, Wu Y, Yuan F, Zhang J (2013) The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis. Arthritis Res Ther 15(5):R161. https://doi.org/10.1186/ar4344
Munoz LE, Janko C, Chaurio RA, Schett G, Gaipl US, Herrmann M (2010) IgG opsonized nuclear remnants from dead cells cause systemic inflammation in SLE. Autoimmunity 43(3):232–235. https://doi.org/10.3109/08916930903510930
Munoz LE, Janko C, Grossmayer GE, Frey B, Voll RE, Kern P, Kalden JR, Schett G, Fietkau R, Herrmann M, Gaipl US (2009) Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum 60(6):1733–1742. https://doi.org/10.1002/art.24535
Glass D, Raum D, Gibson D, Stillman JS, Schur PH (1976) Inherited deficiency of the second component of complement. Rheumatic disease associations. J Clin Invest 58(4):853–861. https://doi.org/10.1172/JCI108538
Helve T, Kurki P, Teppo AM, Wegelius O (1983) DNA antibodies and complement in SLE patients. A follow-up study. Rheumatol Int 3(3):129–132
Teppo AM, Kurki P, Helve T, Wegelius O (1984) DNA antibodies with and without complement-binding ability. Rheumatol Int 4(4):173–176
Sekine H, Ruiz P, Gilkeson GS, Tomlinson S (2011) The dual role of complement in the progression of renal disease in NZB/W F(1) mice and alternative pathway inhibition. Mol Immunol 49(1–2):317–323. https://doi.org/10.1016/j.molimm.2011.09.015
Breda L, Nozzi M, De Sanctis S, Chiarelli F (2010) Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update. Semin Arthritis Rheum 40(1):53–72. https://doi.org/10.1016/j.semarthrit.2008.12.001
Gaipl US, Beyer TD, Heyder P, Kuenkele S, Bottcher A, Voll RE, Kalden JR, Herrmann M (2004) Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin. Arthritis Rheum 50(2):640–649. https://doi.org/10.1002/art.20034
Wang FM, Song D, Pang Y, Song Y, Yu F, Zhao MH (2016) The dysfunctions of complement factor H in lupus nephritis. Lupus 25(12):1328–1340. https://doi.org/10.1177/0961203316642307
Machida T, Sakamoto N, Ishida Y, Takahashi M, Fujita T, Sekine H (2018) Essential roles for mannose-binding lectin-associated serine protease-1/3 in the development of lupus-like glomerulonephritis in MRL/lpr mice. Front Immunol 9:1191. https://doi.org/10.3389/fimmu.2018.01191
Martin M, Leffler J, Blom AM (2012) Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells. J Biol Chem 287(40):33733–33744. https://doi.org/10.1074/jbc.M112.341339
Ferry H, Potter PK, Crockford TL, Nijnik A, Ehrenstein MR, Walport MJ, Botto M, Cornall RJ (2007) Increased positive selection of B1 cells and reduced B cell tolerance to intracellular antigens in c1q-deficient mice. J Immunol 178(5):2916–2922
Iram T, Ramirez-Ortiz Z, Byrne MH, Coleman UA, Kingery ND, Means TK, Frenkel D, El Khoury J (2016) Megf10 is a receptor for C1Q that mediates clearance of apoptotic cells by astrocytes. J Neurosci 36(19):5185–5192. https://doi.org/10.1523/JNEUROSCI.3850-15.2016
Quartier P, Potter PK, Ehrenstein MR, Walport MJ, Botto M (2005) Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro. Eur J Immunol 35(1):252–260. https://doi.org/10.1002/eji.200425497
Mevorach D, Mascarenhas JO, Gershov D, Elkon KB (1998) Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 188(12):2313–2320
Blume KE, Soeroes S, Keppeler H, Stevanovic S, Kretschmer D, Rautenberg M, Wesselborg S, Lauber K (2012) Cleavage of annexin A1 by ADAM10 during secondary necrosis generates a monocytic “find-me” signal. J Immunol 188(1):135–145. https://doi.org/10.4049/jimmunol.1004073
Blume KE, Soeroes S, Waibel M, Keppeler H, Wesselborg S, Herrmann M, Schulze-Osthoff K, Lauber K (2009) Cell surface externalization of annexin A1 as a failsafe mechanism preventing inflammatory responses during secondary necrosis. J Immunol 183(12):8138–8147. https://doi.org/10.4049/jimmunol.0902250
Bruschi M, Petretto A, Vaglio A, Santucci L, Candiano G, Ghiggeri GM (2018) Annexin A1 and autoimmunity: from basic science to clinical applications. Int J Mol Sci 19(5). https://doi.org/10.3390/ijms19051348
Kenis H, van Genderen H, Deckers NM, Lux PA, Hofstra L, Narula J, Reutelingsperger CP (2006) Annexin A5 inhibits engulfment through internalization of PS-expressing cell membrane patches. Exp Cell Res 312(6):719–726. https://doi.org/10.1016/j.yexcr.2005.11.023
Janko C, Jeremic I, Biermann M, Chaurio R, Schorn C, Munoz LE, Herrmann M (2013) Cooperative binding of Annexin A5 to phosphatidylserine on apoptotic cell membranes. Phys Biol 10(6):065006. https://doi.org/10.1088/1478-3975/10/6/065006
Stach CM, Turnay X, Voll RE, Kern PM, Kolowos W, Beyer TD, Kalden JR, Herrmann M (2000) Treatment with annexin V increases immunogenicity of apoptotic human T-cells in Balb/c mice. Cell Death Differ 7(10):911–915. https://doi.org/10.1038/sj.cdd.4400715
Bondanza A, Zimmermann VS, Rovere-Querini P, Turnay J, Dumitriu IE, Stach CM, Voll RE, Gaipl US, Bertling W, Poschl E, Kalden JR, Manfredi AA, Herrmann M (2004) Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J Exp Med 200(9):1157–1165. https://doi.org/10.1084/jem.20040327
Gaipl US, Munoz LE, Rodel F, Pausch F, Frey B, Brachvogel B, von der Mark K, Poschl E (2007) Modulation of the immune system by dying cells and the phosphatidylserine-ligand annexin A5. Autoimmunity 40(4):254–259. https://doi.org/10.1080/08916930701357331
Aleman OR, Mora N, Cortes-Vieyra R, Uribe-Querol E, Rosales C (2016) Differential use of human neutrophil Fcgamma receptors for inducing neutrophil extracellular trap formation. J Immunol Res 2016:2908034–2908017. https://doi.org/10.1155/2016/2908034
Behnen M, Leschczyk C, Moller S, Batel T, Klinger M, Solbach W, Laskay T (2014) Immobilized immune complexes induce neutrophil extracellular trap release by human neutrophil granulocytes via FcgammaRIIIB and Mac-1. J Immunol 193(4):1954–1965. https://doi.org/10.4049/jimmunol.1400478
Chen K, Nishi H, Travers R, Tsuboi N, Martinod K, Wagner DD, Stan R, Croce K, Mayadas TN (2012) Endocytosis of soluble immune complexes leads to their clearance by FcgammaRIIIB but induces neutrophil extracellular traps via FcgammaRIIA in vivo. Blood 120(22):4421–4431. https://doi.org/10.1182/blood-2011-12-401133
Lood C, Arve S, Ledbetter J, Elkon KB (2017) TLR7/8 activation in neutrophils impairs immune complex phagocytosis through shedding of FcgRIIA. J Exp Med 214(7):2103–2119. https://doi.org/10.1084/jem.20161512
Perdomo J, Leung HHL, Ahmadi Z, Yan F, Chong JJH, Passam FH, Chong BH (2019) Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia. Nat Commun 10(1):1322. https://doi.org/10.1038/s41467-019-09160-7
Andrade MF, Kabeya LM, Bortot LO, Santos GBD, Santos EOL, Albiero LR, Figueiredo-Rinhel ASG, Carvalho CA, Azzolini A, Caliri A, Pupo MT, Emery FS, Lucisano-Valim YM (2018) The 3-phenylcoumarin derivative 6,7-dihydroxy-3-[3′,4′-methylenedioxyphenyl]-coumarin downmodulates the FcgammaR- and CR-mediated oxidative metabolism and elastase release in human neutrophils: possible mechanisms underlying inhibition of the formation and release of neutrophil extracellular traps. Free Radic Biol Med 115:421–435. https://doi.org/10.1016/j.freeradbiomed.2017.12.012
Horvei KD, Pedersen HL, Fismen S, Thiyagarajan D, Schneider A, Rekvig OP, Winkler TH, Seredkina N (2017) Lupus nephritis progression in FcgammaRIIB−/−yaa mice is associated with early development of glomerular electron dense deposits and loss of renal DNase I in severe disease. PLoS One 12(11):e0188863. https://doi.org/10.1371/journal.pone.0188863
Weisenburger T, von Neubeck B, Schneider A, Ebert N, Schreyer D, Acs A, Winkler TH (2018) Epistatic interactions between mutations of deoxyribonuclease 1-like 3 and the inhibitory fc gamma receptor IIB result in very early and massive autoantibodies against double-stranded DNA. Front Immunol 9:1551. https://doi.org/10.3389/fimmu.2018.01551
Aleyd E, Al M, Tuk CW, van der Laken CJ, van Egmond M (2016) IgA complexes in plasma and synovial fluid of patients with rheumatoid arthritis induce neutrophil extracellular traps via FcalphaRI. J Immunol 197(12):4552–4559. https://doi.org/10.4049/jimmunol.1502353
Jimenez-Alcazar M, Rangaswamy C, Panda R, Bitterling J, Simsek YJ, Long AT, Bilyy R, Krenn V, Renne C, Renne T, Kluge S, Panzer U, Mizuta R, Mannherz HG, Kitamura D, Herrmann M, Napirei M, Fuchs TA (2017) Host DNases prevent vascular occlusion by neutrophil extracellular traps. Science 358(6367):1202–1206. https://doi.org/10.1126/science.aam8897
Fenton KA, Rekvig OP (2007) A central role of nucleosomes in lupus nephritis. Ann N Y Acad Sci 1108:104–113
Zykova SN, Seredkina N, Benjaminsen J, Rekvig OP (2008) Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB x NZW)F(1) mice. Arthritis Rheum 58(3):813–825. https://doi.org/10.1002/art.23276
Mjelle JE, Kalaaji M, Rekvig OP (2009) Exposure of chromatin and not high affinity for dsDNA determines the nephritogenic impact of anti-dsDNA antibodies in (NZBxNZW)F1 mice. Autoimmunity 42(2):104–111. https://doi.org/10.1080/08916930802375729
Fismen S, Mortensen ES, Rekvig OP (2011) Nuclease deficiencies promote end-stage lupus nephritis but not nephritogenic autoimmunity in (NZB x NZW) F1 mice. Immunol Cell Biol 89(1):90–99. https://doi.org/10.1038/icb.2010.75
Fenton K, Fismen S, Hedberg A, Seredkina N, Fenton C, Mortensen ES, Rekvig OP (2009) Anti-dsDNA antibodies promote initiation, and acquired loss of renal Dnase1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice. PLoS One 4(12):e8474. https://doi.org/10.1371/journal.pone.0008474
Hedberg A, Fismen S, Fenton KA, Mortensen ES, Rekvig OP (2010) Deposition of chromatin-IgG complexes in skin of nephritic MRL-lpr/lpr mice is associated with increased local matrix metalloprotease activities. Exp Dermatol 19(8):e265–e274. https://doi.org/10.1111/j.1600-0625.2010.01064.x
Thiyagarajan D, Rekvig OP, Seredkina N (2015) TNFalpha amplifies DNaseI expression in renal tubular cells while IL-1beta promotes nuclear DNaseI translocation in an endonuclease-inactive form. PLoS One 10(6):e0129485. https://doi.org/10.1371/journal.pone.0129485
Gershwin ME, Shultz L (1985) Mechanisms of genetically determined immune dysfunction. Immunol Today 6(2):36–37. https://doi.org/10.1016/0167-5699(85)90041-6
Pedersen HL, Horvei KD, Thiyagarajan D, Norby GE, Seredkina N, Moroni G, Eilertsen GO, Holdaas H, Strom EH, Bakland G, Meroni PL, Rekvig OP (2018) Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression. The journal of pathology Clinical research 4(3):193–203. https://doi.org/10.1002/cjp2.99
Yagnik DR, Hillyer P, Marshall D, Smythe CD, Krausz T, Haskard DO, Landis RC (2000) Noninflammatory phagocytosis of monosodium urate monohydrate crystals by mouse macrophages. Implications for the control of joint inflammation in gout. Arthritis Rheum 43(8):1779–1789. https://doi.org/10.1002/1529-0131(200008)43:8<1779::AID-ANR14>3.0.CO;2-2
Yuan XM, Li W, Brunk UT, Dalen H, Chang YH, Sevanian A (2000) Lysosomal destabilization during macrophage damage induced by cholesterol oxidation products. Free Radic Biol Med 28(2):208–218
Cui D, Thorp E, Li Y, Wang N, Yvan-Charvet L, Tall AR, Tabas I (2007) Pivotal advance: macrophages become resistant to cholesterol-induced death after phagocytosis of apoptotic cells. J Leukoc Biol 82(5):1040–1050. https://doi.org/10.1189/jlb.0307192
Li Y, Gerbod-Giannone MC, Seitz H, Cui D, Thorp E, Tall AR, Matsushima GK, Tabas I (2006) Cholesterol-induced apoptotic macrophages elicit an inflammatory response in phagocytes, which is partially attenuated by the Mer receptor. J Biol Chem 281(10):6707–6717. https://doi.org/10.1074/jbc.M510579200
Hamon Y, Broccardo C, Chambenoit O, Luciani MF, Toti F, Chaslin S, Freyssinet JM, Devaux PF, McNeish J, Marguet D, Chimini G (2000) ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol 2(7):399–406. https://doi.org/10.1038/35017029
Grainger DJ, Reckless J, McKilligin E (2004) Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice. J Immunol 173(10):6366–6375
Kawane K, Ohtani M, Miwa K, Kizawa T, Kanbara Y, Yoshioka Y, Yoshikawa H, Nagata S (2006) Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443(7114):998–1002. https://doi.org/10.1038/nature05245
Ippolito A, Petri M (2008) An update on mortality in systemic lupus erythematosus. Clin Exp Rheumatol 26(5 Suppl 51):S72–S79
Maria NI, Davidson A (2017) Renal macrophages and dendritic cells in SLE nephritis. Curr Rheumatol Rep 19(12):81. https://doi.org/10.1007/s11926-017-0708-y
Ravishankar B, Liu H, Shinde R, Chaudhary K, Xiao W, Bradley J, Koritzinsky M, Madaio MP, McGaha TL (2015) The amino acid sensor GCN2 inhibits inflammatory responses to apoptotic cells promoting tolerance and suppressing systemic autoimmunity. Proc Natl Acad Sci U S A 112(34):10774–10779. https://doi.org/10.1073/pnas.1504276112
Marek I, Becker R, Fahlbusch FB, Menendez-Castro C, Rascher W, Daniel C, Volkert G, Hartner A (2018) Expression of the Alpha8 integrin chain facilitates phagocytosis by renal mesangial cells. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 45(6):2161–2173. https://doi.org/10.1159/000488160
Kimura T, Isaka Y, Yoshimori T (2017) Autophagy and kidney inflammation. Autophagy 13(6):997–1003. https://doi.org/10.1080/15548627.2017.1309485
Brooks CR, Yeung MY, Brooks YS, Chen H, Ichimura T, Henderson JM, Bonventre JV (2015) KIM-1-/TIM-1-mediated phagocytosis links ATG5-/ULK1-dependent clearance of apoptotic cells to antigen presentation. EMBO J 34(19):2441–2464. https://doi.org/10.15252/embj.201489838
Yang L, Brooks CR, Xiao S, Sabbisetti V, Yeung MY, Hsiao LL, Ichimura T, Kuchroo V, Bonventre JV (2015) KIM-1-mediated phagocytosis reduces acute injury to the kidney. J Clin Invest 125(4):1620–1636. https://doi.org/10.1172/JCI75417
Ismail OZ, Sriranganathan S, Zhang X, Bonventre JV, Zervos AS, Gunaratnam L (2018) Tctex-1, a novel interaction partner of kidney injury molecule-1, is required for efferocytosis. J Cell Physiol 233(10):6877–6895. https://doi.org/10.1002/jcp.26578
Cen C, Aziz M, Yang WL, Zhou M, Nicastro JM, Coppa GF, Wang P (2017) Milk fat globule-epidermal growth factor-factor VIII attenuates sepsis-induced acute kidney injury. J Surg Res 213:281–289. https://doi.org/10.1016/j.jss.2017.02.024
Demers M, Krause DS, Schatzberg D, Martinod K, Voorhees JR, Fuchs TA, Scadden DT, Wagner DD (2012) Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci U S A 109(32):13076–13081. https://doi.org/10.1073/pnas.1200419109
Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr, Wrobleski SK, Wakefield TW, Hartwig JH, Wagner DD (2010) Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 107(36):15880–15885. https://doi.org/10.1073/pnas.1005743107
Chitrabamrung S, Rubin RL, Tan EM (1981) Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol Int 1(2):55–60
Al-Mayouf SM, Sunker A, Abdwani R, Abrawi SA, Almurshedi F, Alhashmi N, Al Sonbul A, Sewairi W, Qari A, Abdallah E, Al-Owain M, Al Motywee S, Al-Rayes H, Hashem M, Khalak H, Al-Jebali L, Alkuraya FS (2011) Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat Genet 43(12):1186–1188. https://doi.org/10.1038/ng.975
Leppkes M, Maueroder C, Hirth S, Nowecki S, Gunther C, Billmeier U, Paulus S, Biermann M, Munoz LE, Hoffmann M, Wildner D, Croxford AL, Waisman A, Mowen K, Jenne DE, Krenn V, Mayerle J, Lerch MM, Schett G, Wirtz S, Neurath MF, Herrmann M, Becker C (2016) Externalized decondensed neutrophil chromatin occludes pancreatic ducts and drives pancreatitis. Nat Commun 7:10973. https://doi.org/10.1038/ncomms10973
Maueroder C, Mahajan A, Paulus S, Gosswein S, Hahn J, Kienhofer D, Biermann MH, Tripal P, Friedrich RP, Munoz LE, Neurath MF, Becker C, Schett GA, Herrmann M, Leppkes M (2016) Menage-a-trois: the ratio of bicarbonate to CO2 and the pH regulate the capacity of neutrophils to form NETs. Front Immunol 7:583. https://doi.org/10.3389/fimmu.2016.00583
Bilyy R, Fedorov V, Vovk V, Leppkes M, Dumych T, Chopyak V, Schett G, Herrmann M (2016) Neutrophil extracellular traps form a barrier between necrotic and viable areas in acute abdominal inflammation. Front Immunol 7:424. https://doi.org/10.3389/fimmu.2016.00424
Kalra MG, Higgins KE, Kinney BS (2014) Intertrigo and secondary skin infections. Am Fam Physician 89(7):569–573
Greidinger EL, Casciola-Rosen L, Morris SM, Hoffman RW, Rosen A (2000) Autoantibody recognition of distinctly modified forms of the U1-70-kd antigen is associated with different clinical disease manifestations. Arthritis Rheum 43(4):881–888. https://doi.org/10.1002/1529-0131(200004)43:4<881::AID-ANR20>3.0.CO;2-G
Hall JC, Casciola-Rosen L, Rosen A (2004) Altered structure of autoantigens during apoptosis. Rheum Dis Clin N Am 30(3):455–471, vii. https://doi.org/10.1016/j.rdc.2004.04.012
Crow MK (2014) Advances in understanding the role of type I interferons in systemic lupus erythematosus. Curr Opin Rheumatol 26(5):467–474. https://doi.org/10.1097/BOR.0000000000000087
Krapf F, Herrmann M, Leitmann W, Kalden JR (1989) Antibody binding of macromolecular DNA and RNA in the plasma of SLE patients. Clin Exp Immunol 75(3):336–342
Gheorghiu M (1996) The ocular manifestations in systemic lupus erythematosus. Oftalmologia 40(2):100–104
Preble JM, Silpa-archa S, Foster CS (2015) Ocular involvement in systemic lupus erythematosus. Curr Opin Ophthalmol 26(6):540–545. https://doi.org/10.1097/ICU.0000000000000209
Thanabalasuriar A, Scott BNV, Peiseler M, Willson ME, Zeng Z, Warrener P, Keller AE, Surewaard BGJ, Dozier EA, Korhonen JT, Cheng LI, Gadjeva M, Stover CK, DiGiandomenico A, Kubes P (2019) Neutrophil extracellular traps confine Pseudomonas aeruginosa ocular biofilms and restrict brain invasion. Cell host & microbe 25(4):526–536 e4. https://doi.org/10.1016/j.chom.2019.02.007
Mohanty T, Sjogren J, Kahn F, Abu-Humaidan AH, Fisker N, Assing K, Morgelin M, Bengtsson AA, Borregaard N, Sorensen OE (2015) A novel mechanism for NETosis provides antimicrobial defense at the oral mucosa. Blood 126(18):2128–2137. https://doi.org/10.1182/blood-2015-04-641142
Papillon MM, Lefèvre P (1924) Deux cas de kératodermie palmaire et plantaire symétrique familiale (maladie de Meleda) chez le frère et la soeur., Bulletin de la Société française de dermatologie et de vénéorologie, Paris. Deux cas de kératodermie palmaire et plantaire symétrique familiale (maladie de Meleda) chez le frère et la soeur. Coexistence dans les deux cas d’altérations dentaires graves 31:82–87
Dekker G, Jansen LH (1956) Hyperkeratosis palmo-plantaris with periodontosis (Papillon-Lefevre). Dermatologica 113(4):207–219
Hahn J, Schauer C, Czegley C, Kling L, Petru L, Schmid B, Weidner D, Reinwald C, Biermann MHC, Blunder S, Ernst J, Lesner A, Bauerle T, Palmisano R, Christiansen S, Herrmann M, Bozec A, Gruber R, Schett G, Hoffmann MH (2019) Aggregated neutrophil extracellular traps resolve inflammation by proteolysis of cytokines and chemokines and protection from antiproteases. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 33(1):1401–1414. https://doi.org/10.1096/fj.201800752R
Hartl D (2015) Oral NETs: the deadly kiss. Blood 126(18):2079–2080. https://doi.org/10.1182/blood-2015-08-664003
Schiodt M (1984) Oral discoid lupus erythematosus. II. Skin lesions and systemic lupus erythematosus in sixty-six patients with 6-year follow-up. Oral surgery, oral medicine, and oral pathology 57(2):177–180
Zuercher AW, Spirig R, Baz Morelli A, Rowe T, Kasermann F (2019) Next-generation Fc receptor-targeting biologics for autoimmune diseases. Autoimmun Rev 102366:102366. https://doi.org/10.1016/j.autrev.2019.102366
Lood C, Allhorn M, Lood R, Gullstrand B, Olin AI, Ronnblom L, Truedsson L, Collin M, Bengtsson AA (2012) IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: a possible new treatment? Arthritis Rheum 64(8):2698–2706. https://doi.org/10.1002/art.34454
Gomez-Guzman M, Jimenez R, Romero M, Sanchez M, Zarzuelo MJ, Gomez-Morales M, O'Valle F, Lopez-Farre AJ, Algieri F, Galvez J, Perez-Vizcaino F, Sabio JM, Duarte J (2014) Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus. Hypertension 64(2):330–337. https://doi.org/10.1161/HYPERTENSIONAHA.114.03587
Virdis A, Tani C, Duranti E, Vagnani S, Carli L, Kuhl AA, Solini A, Baldini C, Talarico R, Bombardieri S, Taddei S, Mosca M (2015) Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus. Arthritis research & therapy 17:277. https://doi.org/10.1186/s13075-015-0790-3
Kienhofer D, Boeltz S, Hoffmann MH (2016) Reactive oxygen homeostasis - the balance for preventing autoimmunity. Lupus 25(8):943–954. https://doi.org/10.1177/0961203316640919
Lauber K, Keppeler H, Munoz LE, Koppe U, Schroder K, Yamaguchi H, Kronke G, Uderhardt S, Wesselborg S, Belka C, Nagata S, Herrmann M (2013) Milk fat globule-EGF factor 8 mediates the enhancement of apoptotic cell clearance by glucocorticoids. Cell Death Differ 20(9):1230–1240. https://doi.org/10.1038/cdd.2013.82
Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270(5234):286–290
Cronstein BN, Eberle MA, Gruber HE, Levin RI (1991) Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci U S A 88(6):2441–2445. https://doi.org/10.1073/pnas.88.6.2441
Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, Soppet D, Charters M, Gentz R, Parmelee D, Li Y, Galperina O, Giri J, Roschke V, Nardelli B, Carrell J, Sosnovtseva S, Greenfield W, Ruben SM, Olsen HS, Fikes J, Hilbert DM (1999) BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285(5425):260–263
Yildirim-Toruner C, Diamond B (2011) Current and novel therapeutics in the treatment of systemic lupus erythematosus. J Allergy Clin Immunol 127(2):303–312; quiz 313-4. https://doi.org/10.1016/j.jaci.2010.12.1087
Gottschalk TA, Tsantikos E, Hibbs ML (2015) Pathogenic inflammation and its therapeutic targeting in systemic lupus erythematosus. Front Immunol 6:550. https://doi.org/10.3389/fimmu.2015.00550
Funding
This study is supported by the Deutsche Forschungsgemeinschaft (DFG) and Friedrich-Alexander Universität Erlangen-Nürnberg (FAU) within the funding program Open Access Publishing. This work was partially supported by the German Research Foundation (DFG) to MH (CRC1181-C03, KFO257) by the Volkswagen-Stiftung grant no. 90361 to MH and by the doctoral training program GK1660 of the DFG to JK.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
This article is a contribution to the special issue on Resolution of Inflammation in Chronic Diseases – Guest Editor: Markus Neurath
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Boeltz, S., Hagen, M., Knopf, J. et al. Towards a pro-resolving concept in systemic lupus erythematosus. Semin Immunopathol 41, 681–697 (2019). https://doi.org/10.1007/s00281-019-00760-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00281-019-00760-5